(Q43145386)

14 November 2017

title

Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States (English)

1 reference

14 November 2017

main subject

United States of America

0 references

1 reference

1 reference

1

David Y Graham

1 reference

14 November 2017

Syed Ussama Javed

2

1 reference

14 November 2017

Sara Keihanian

series ordinal

3

1 reference

14 November 2017

Suhaib Abudayyeh

series ordinal

4

1 reference

14 November 2017

Antone R Opekun

series ordinal

5

1 reference

14 November 2017

publication date

2 March 2010

1 reference

Journal of Gastroenterology

14 November 2017

published in

1 reference

14 November 2017

volume

45

1 reference

14 November 2017

issue

8

1 reference

14 November 2017

page(s)

816-820

1 reference

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

14 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-010-0220-X

Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface

21 January 2018

1 reference

12 December 2020

Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy

1 reference

12 December 2020

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

1 reference

12 December 2020

Therapeutic impact of CYP2C19 pharmacogenetics on proton pump inhibitor-based eradication therapy for Helicobacter pylori

1 reference

12 December 2020

Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection.

1 reference

12 December 2020

Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study

1 reference

12 December 2020

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

1 reference

12 December 2020

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

1 reference

12 December 2020

New concepts of resistance in the treatment of Helicobacter pylori infections

1 reference

12 December 2020

Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies

1 reference

12 December 2020

Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

1 reference

12 December 2020

Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.

1 reference

12 December 2020

Short report: high-dose omeprazole and amoxycillin in the treatment of Helicobacter pylori-associated duodenal ulcer

1 reference

12 December 2020

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy

1 reference

12 December 2020

High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication

1 reference

12 December 2020

CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori

1 reference

12 December 2020

Enhanced eradication of Helicobacter pylori by pre- versus post-prandial amoxycillin suspension with omeprazole: implications for antibiotic delivery

1 reference

12 December 2020

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

1 reference

12 December 2020

Short-term therapy with high dosage omeprazole and amoxicillin for Helicobacter pylori eradication. A pilot study

1 reference

12 December 2020

Eradication of Helicobacter pylori in peptic ulcer disease with amoxycillin, 2.0 g, and omeprazole, 80 or 120 mg: a prospective randomized trial

1 reference

12 December 2020

Proton pump inhibitors--their pharmacological impact on the clinical management of acid-related disorders

1 reference

12 December 2020

The life and death of Helicobacter pylori

1 reference

12 December 2020

Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success

1 reference

12 December 2020

Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection

1 reference

12 December 2020

Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens.

1 reference

12 December 2020

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

1 reference

12 December 2020

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori

1 reference

12 December 2020

Seven-day therapy for Helicobacter pylori in the United States

1 reference

12 December 2020

Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.

1 reference

12 December 2020

A report card to grade Helicobacter pylori therapy

1 reference

12 December 2020

Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics

1 reference

12 December 2020

Optimal dose of omeprazole in combination with amoxicillin in eradicating H. pylori and preventing relapses in duodenal ulcer patients.

1 reference

12 December 2020

Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.

1 reference

12 December 2020

Helicobacter pylori: the challenge in therapy

1 reference

12 December 2020

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

1 reference

12 December 2020

Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease

1 reference

12 December 2020

Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment

1 reference

12 December 2020

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

1 reference

12 December 2020

Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection

1 reference

12 December 2020

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

1 reference

12 December 2020

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

12 December 2020

Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer

1 reference

12 December 2020

Cure rate of high dose omeprazole and amoxicillin therapy for treatment-resistant Helicobacter pylori infection

1 reference

12 December 2020

Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.

1 reference

12 December 2020

High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin

1 reference

12 December 2020

Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism

1 reference

12 December 2020

Dose-response of omeprazole combined with amoxycillin on duodenal ulcer healing and eradication of Helicobacter pylori

1 reference

12 December 2020

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin

1 reference

12 December 2020

Treatment of Helicobacter pylori infection: a review of the world literature

1 reference

12 December 2020

Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori

1 reference

12 December 2020

Efficient identification and evaluation of effective Helicobacter pylori therapies

1 reference

12 December 2020

Does Helicobacter pylori eradication depend on the period of amoxicillin treatment? A retrospective study

1 reference

12 December 2020

Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals

1 reference

12 December 2020

10.1007/S00535-010-0220-X

Identifiers

DOI

1 reference

14 November 2017

1 reference